Median radiographic progression-free survival was 138 months ( 95 % CI 131-149 ) with orteronel plus prednisone and 87 months ( 83-109 ) with placebo plus prednisone ( hazard ratio [ HR ] 071 , 95 % CI 063-080 ; p < 00001 ) .